Summary: MAPS Founder and Executive Director Rick Doblin, Ph.D., joins FOX News Radio’s Kennedy Saves the World Podcast to explain the results of MAPS’ first Phase 3 clinical trial investigating the use of MDMA-assisted therapy in in the treatment of PTSD. Doblin also shares the complicated historical context that serves as a backdrop for current progress in psychedelic research.
Originally appearing here.
This week, Kennedy sits down with Founder and Executive Director of the Multidisciplinary Association for Psychedelic Studies Rick Doblin to discuss the role of MDMA-guided psychotherapy in treating PTSD.
Rick shares the story of how he developed a passion for healing the brain with psychedelics and the 35-year journey he’s endured to build a growing non-profit organization. He also explains how to effectively work with drugs that have been aggressively stigmatized and politicized.
